nodes	percent_of_prediction	percent_of_DWPC	metapath
Topiramate—Hypocholesterolaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0684	0.0727	CcSEcCtD
Topiramate—Unspecified disorder of autonomic nervous system—Cyclosporine—focal segmental glomerulosclerosis	0.0297	0.0316	CcSEcCtD
Topiramate—Autonomic neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0251	0.0267	CcSEcCtD
Topiramate—Hallucination, visual—Cyclosporine—focal segmental glomerulosclerosis	0.0218	0.0232	CcSEcCtD
Topiramate—Gingival hyperplasia—Cyclosporine—focal segmental glomerulosclerosis	0.0212	0.0225	CcSEcCtD
Topiramate—Pharyngeal oedema—Cyclosporine—focal segmental glomerulosclerosis	0.0199	0.0212	CcSEcCtD
Topiramate—GRIK4—kidney—focal segmental glomerulosclerosis	0.0176	0.297	CbGeAlD
Topiramate—Hypertrichosis—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.0159	CcSEcCtD
Topiramate—GRIK5—cortex of kidney—focal segmental glomerulosclerosis	0.0125	0.211	CbGeAlD
Topiramate—Altered state of consciousness—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0131	CcSEcCtD
Topiramate—Pancreatitis acute—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0131	CcSEcCtD
Topiramate—Leukorrhea—Cyclosporine—focal segmental glomerulosclerosis	0.0122	0.0129	CcSEcCtD
Topiramate—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0127	CcSEcCtD
Topiramate—Nephropathy—Cyclosporine—focal segmental glomerulosclerosis	0.012	0.0127	CcSEcCtD
Topiramate—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0118	0.0125	CcSEcCtD
Topiramate—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.0103	0.0109	CcSEcCtD
Topiramate—Gingival bleeding—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0107	CcSEcCtD
Topiramate—Micturition urgency—Cyclosporine—focal segmental glomerulosclerosis	0.01	0.0107	CcSEcCtD
Topiramate—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0097	0.0103	CcSEcCtD
Topiramate—Cerebration impaired—Cyclosporine—focal segmental glomerulosclerosis	0.0097	0.0103	CcSEcCtD
Topiramate—Vaginal discharge—Cyclosporine—focal segmental glomerulosclerosis	0.00937	0.00996	CcSEcCtD
Topiramate—Libido increased—Cyclosporine—focal segmental glomerulosclerosis	0.00937	0.00996	CcSEcCtD
Topiramate—Encephalopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00888	0.00944	CcSEcCtD
Topiramate—Tooth disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.00934	CcSEcCtD
Topiramate—Nail disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00879	0.00934	CcSEcCtD
Topiramate—Menstrual disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00836	0.00889	CcSEcCtD
Topiramate—Burning sensation—Cyclosporine—focal segmental glomerulosclerosis	0.00821	0.00872	CcSEcCtD
Topiramate—Influenza-like symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00798	0.00848	CcSEcCtD
Topiramate—Hyperlipidaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00791	0.00841	CcSEcCtD
Topiramate—Tongue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00784	0.00833	CcSEcCtD
Topiramate—Coagulopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00732	0.00778	CcSEcCtD
Topiramate—Hyperaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00772	CcSEcCtD
Topiramate—Gingivitis—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00772	CcSEcCtD
Topiramate—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.00698	0.00742	CcSEcCtD
Topiramate—Acne—Cyclosporine—focal segmental glomerulosclerosis	0.00677	0.0072	CcSEcCtD
Topiramate—Disturbance in attention—Cyclosporine—focal segmental glomerulosclerosis	0.00658	0.00699	CcSEcCtD
Topiramate—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.00653	0.00694	CcSEcCtD
Topiramate—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00649	0.0069	CcSEcCtD
Topiramate—Amenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00649	0.0069	CcSEcCtD
Topiramate—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.00635	0.00675	CcSEcCtD
Topiramate—Viral infection—Cyclosporine—focal segmental glomerulosclerosis	0.00631	0.00671	CcSEcCtD
Topiramate—Dysmenorrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00666	CcSEcCtD
Topiramate—Arthropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00666	CcSEcCtD
Topiramate—CA7—kidney—focal segmental glomerulosclerosis	0.00624	0.105	CbGeAlD
Topiramate—Glossitis—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00658	CcSEcCtD
Topiramate—Lacrimation increased—Cyclosporine—focal segmental glomerulosclerosis	0.00619	0.00658	CcSEcCtD
Topiramate—Nocturia—Cyclosporine—focal segmental glomerulosclerosis	0.00615	0.00653	CcSEcCtD
Topiramate—Creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.00637	CcSEcCtD
Topiramate—Hearing impaired—Cyclosporine—focal segmental glomerulosclerosis	0.00599	0.00637	CcSEcCtD
Topiramate—Influenza like illness—Cyclosporine—focal segmental glomerulosclerosis	0.00554	0.00588	CcSEcCtD
Topiramate—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.00585	CcSEcCtD
Topiramate—Candida infection—Cyclosporine—focal segmental glomerulosclerosis	0.00544	0.00578	CcSEcCtD
Topiramate—Fluid retention—Cyclosporine—focal segmental glomerulosclerosis	0.00541	0.00575	CcSEcCtD
Topiramate—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.00569	CcSEcCtD
Topiramate—Cramps of lower extremities—Cyclosporine—focal segmental glomerulosclerosis	0.00524	0.00557	CcSEcCtD
Topiramate—Oesophagitis—Cyclosporine—focal segmental glomerulosclerosis	0.00521	0.00554	CcSEcCtD
Topiramate—Urine output increased—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00548	CcSEcCtD
Topiramate—Neoplasm—Cyclosporine—focal segmental glomerulosclerosis	0.00515	0.00548	CcSEcCtD
Topiramate—Abnormal vision—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.00528	CcSEcCtD
Topiramate—Mental disability—Cyclosporine—focal segmental glomerulosclerosis	0.00495	0.00526	CcSEcCtD
Topiramate—Lymphadenopathy—Cyclosporine—focal segmental glomerulosclerosis	0.00485	0.00516	CcSEcCtD
Topiramate—Diabetes mellitus—Cyclosporine—focal segmental glomerulosclerosis	0.00476	0.00506	CcSEcCtD
Topiramate—Polyuria—Cyclosporine—focal segmental glomerulosclerosis	0.00471	0.00501	CcSEcCtD
Topiramate—Gastroenteritis—Cyclosporine—focal segmental glomerulosclerosis	0.00467	0.00496	CcSEcCtD
Topiramate—Disorientation—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00492	CcSEcCtD
Topiramate—Deafness—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00492	CcSEcCtD
Topiramate—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00463	0.00492	CcSEcCtD
Topiramate—Eczema—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00489	CcSEcCtD
Topiramate—Hepatic failure—Cyclosporine—focal segmental glomerulosclerosis	0.0046	0.00489	CcSEcCtD
Topiramate—Eye pain—Cyclosporine—focal segmental glomerulosclerosis	0.00458	0.00487	CcSEcCtD
Topiramate—Libido decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00446	0.00474	CcSEcCtD
Topiramate—Hot flush—Cyclosporine—focal segmental glomerulosclerosis	0.00442	0.0047	CcSEcCtD
Topiramate—Increased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.00468	CcSEcCtD
Topiramate—Menopausal symptoms—Cyclosporine—focal segmental glomerulosclerosis	0.00439	0.00466	CcSEcCtD
Topiramate—Visual disturbance—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00464	CcSEcCtD
Topiramate—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.00429	0.00456	CcSEcCtD
Topiramate—Hypoglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00424	0.00451	CcSEcCtD
Topiramate—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.00422	0.00449	CcSEcCtD
Topiramate—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.00414	0.0044	CcSEcCtD
Topiramate—Disturbance in sexual arousal—Cyclosporine—focal segmental glomerulosclerosis	0.00411	0.00436	CcSEcCtD
Topiramate—Migraine—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00433	CcSEcCtD
Topiramate—Affect lability—Cyclosporine—focal segmental glomerulosclerosis	0.00407	0.00433	CcSEcCtD
Topiramate—CA12—kidney—focal segmental glomerulosclerosis	0.00405	0.0685	CbGeAlD
Topiramate—Mood swings—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00417	CcSEcCtD
Topiramate—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.00388	0.00412	CcSEcCtD
Topiramate—Abdominal pain upper—Cyclosporine—focal segmental glomerulosclerosis	0.00378	0.00402	CcSEcCtD
Topiramate—Breast disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00374	0.00397	CcSEcCtD
Topiramate—Gastritis—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00389	CcSEcCtD
Topiramate—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00365	0.00388	CcSEcCtD
Topiramate—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0036	0.00383	CcSEcCtD
Topiramate—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00358	0.0038	CcSEcCtD
Topiramate—Pancreatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00351	0.00373	CcSEcCtD
Topiramate—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00348	0.0037	CcSEcCtD
Topiramate—Bronchitis—Cyclosporine—focal segmental glomerulosclerosis	0.00344	0.00366	CcSEcCtD
Topiramate—Abdominal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00343	0.00364	CcSEcCtD
Topiramate—Dysuria—Cyclosporine—focal segmental glomerulosclerosis	0.00334	0.00355	CcSEcCtD
Topiramate—Upper respiratory tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00332	0.00353	CcSEcCtD
Topiramate—Pollakiuria—Cyclosporine—focal segmental glomerulosclerosis	0.0033	0.00351	CcSEcCtD
Topiramate—Weight increased—Cyclosporine—focal segmental glomerulosclerosis	0.00325	0.00346	CcSEcCtD
Topiramate—Weight decreased—Cyclosporine—focal segmental glomerulosclerosis	0.00324	0.00344	CcSEcCtD
Topiramate—Hyperglycaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00323	0.00343	CcSEcCtD
Topiramate—CA1—kidney—focal segmental glomerulosclerosis	0.00321	0.0543	CbGeAlD
Topiramate—Pneumonia—Cyclosporine—focal segmental glomerulosclerosis	0.00321	0.00341	CcSEcCtD
Topiramate—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00339	CcSEcCtD
Topiramate—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00319	0.00339	CcSEcCtD
Topiramate—Depression—Cyclosporine—focal segmental glomerulosclerosis	0.00318	0.00338	CcSEcCtD
Topiramate—Renal failure—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00333	CcSEcCtD
Topiramate—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00313	0.00332	CcSEcCtD
Topiramate—Stomatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00311	0.0033	CcSEcCtD
Topiramate—Conjunctivitis—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00329	CcSEcCtD
Topiramate—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.0031	0.00329	CcSEcCtD
Topiramate—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00304	0.00323	CcSEcCtD
Topiramate—Epistaxis—Cyclosporine—focal segmental glomerulosclerosis	0.00301	0.0032	CcSEcCtD
Topiramate—Sinusitis—Cyclosporine—focal segmental glomerulosclerosis	0.00299	0.00318	CcSEcCtD
Topiramate—Haemoglobin—Cyclosporine—focal segmental glomerulosclerosis	0.00288	0.00306	CcSEcCtD
Topiramate—Rhinitis—Cyclosporine—focal segmental glomerulosclerosis	0.00287	0.00305	CcSEcCtD
Topiramate—Hepatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00304	CcSEcCtD
Topiramate—Haemorrhage—Cyclosporine—focal segmental glomerulosclerosis	0.00286	0.00304	CcSEcCtD
Topiramate—CA4—nephron tubule—focal segmental glomerulosclerosis	0.00286	0.0483	CbGeAlD
Topiramate—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00285	0.00303	CcSEcCtD
Topiramate—Pharyngitis—Cyclosporine—focal segmental glomerulosclerosis	0.00284	0.00302	CcSEcCtD
Topiramate—Urinary tract disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00283	0.003	CcSEcCtD
Topiramate—Connective tissue disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00299	CcSEcCtD
Topiramate—Urethral disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00281	0.00298	CcSEcCtD
Topiramate—Visual impairment—Cyclosporine—focal segmental glomerulosclerosis	0.00276	0.00293	CcSEcCtD
Topiramate—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00267	0.00284	CcSEcCtD
Topiramate—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00266	0.00282	CcSEcCtD
Topiramate—Angiopathy—Cyclosporine—focal segmental glomerulosclerosis	0.0026	0.00276	CcSEcCtD
Topiramate—Mediastinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00258	0.00274	CcSEcCtD
Topiramate—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00257	0.00273	CcSEcCtD
Topiramate—Alopecia—Cyclosporine—focal segmental glomerulosclerosis	0.00253	0.00269	CcSEcCtD
Topiramate—CA4—kidney—focal segmental glomerulosclerosis	0.00251	0.0424	CbGeAlD
Topiramate—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00251	0.00267	CcSEcCtD
Topiramate—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00249	0.00265	CcSEcCtD
Topiramate—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00246	0.00261	CcSEcCtD
Topiramate—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00245	0.0026	CcSEcCtD
Topiramate—CA4—cortex of kidney—focal segmental glomerulosclerosis	0.00244	0.0413	CbGeAlD
Topiramate—Dysgeusia—Cyclosporine—focal segmental glomerulosclerosis	0.00244	0.00259	CcSEcCtD
Topiramate—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00242	0.00257	CcSEcCtD
Topiramate—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.0024	0.00255	CcSEcCtD
Topiramate—CA2—nephron tubule—focal segmental glomerulosclerosis	0.00237	0.04	CbGeAlD
Topiramate—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00235	0.0025	CcSEcCtD
Topiramate—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00233	0.00248	CcSEcCtD
Topiramate—Ill-defined disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00231	0.00246	CcSEcCtD
Topiramate—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0023	0.00245	CcSEcCtD
Topiramate—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00229	0.00243	CcSEcCtD
Topiramate—Malaise—Cyclosporine—focal segmental glomerulosclerosis	0.00225	0.00239	CcSEcCtD
Topiramate—Vertigo—Cyclosporine—focal segmental glomerulosclerosis	0.00224	0.00238	CcSEcCtD
Topiramate—Leukopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00223	0.00237	CcSEcCtD
Topiramate—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00217	0.00231	CcSEcCtD
Topiramate—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00216	0.0023	CcSEcCtD
Topiramate—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00215	0.00229	CcSEcCtD
Topiramate—Chest pain—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00226	CcSEcCtD
Topiramate—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00226	CcSEcCtD
Topiramate—Myalgia—Cyclosporine—focal segmental glomerulosclerosis	0.00212	0.00226	CcSEcCtD
Topiramate—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00225	CcSEcCtD
Topiramate—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00211	0.00224	CcSEcCtD
Topiramate—Discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.0021	0.00223	CcSEcCtD
Topiramate—CA2—kidney—focal segmental glomerulosclerosis	0.00208	0.0352	CbGeAlD
Topiramate—Dry mouth—Cyclosporine—focal segmental glomerulosclerosis	0.00207	0.00221	CcSEcCtD
Topiramate—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00205	0.00218	CcSEcCtD
Topiramate—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00203	0.00216	CcSEcCtD
Topiramate—CA2—cortex of kidney—focal segmental glomerulosclerosis	0.00203	0.0342	CbGeAlD
Topiramate—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.00202	0.00215	CcSEcCtD
Topiramate—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00212	CcSEcCtD
Topiramate—Thrombocytopenia—Cyclosporine—focal segmental glomerulosclerosis	0.00199	0.00212	CcSEcCtD
Topiramate—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00198	0.0021	CcSEcCtD
Topiramate—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00197	0.00209	CcSEcCtD
Topiramate—Anorexia—Cyclosporine—focal segmental glomerulosclerosis	0.00194	0.00206	CcSEcCtD
Topiramate—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00185	0.00197	CcSEcCtD
Topiramate—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00184	0.00196	CcSEcCtD
Topiramate—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00183	0.00194	CcSEcCtD
Topiramate—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00193	CcSEcCtD
Topiramate—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00181	0.00192	CcSEcCtD
Topiramate—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00179	0.0019	CcSEcCtD
Topiramate—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00177	0.00188	CcSEcCtD
Topiramate—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00176	0.00187	CcSEcCtD
Topiramate—Fatigue—Cyclosporine—focal segmental glomerulosclerosis	0.00175	0.00186	CcSEcCtD
Topiramate—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00185	CcSEcCtD
Topiramate—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00174	0.00185	CcSEcCtD
Topiramate—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00168	0.00178	CcSEcCtD
Topiramate—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00166	0.00177	CcSEcCtD
Topiramate—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.00162	0.00172	CcSEcCtD
Topiramate—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00171	CcSEcCtD
Topiramate—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00161	0.00171	CcSEcCtD
Topiramate—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.0015	0.00159	CcSEcCtD
Topiramate—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00146	0.00155	CcSEcCtD
Topiramate—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00144	0.00153	CcSEcCtD
Topiramate—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00139	0.00148	CcSEcCtD
Topiramate—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00134	0.00143	CcSEcCtD
Topiramate—CYP3A4—kidney—focal segmental glomerulosclerosis	0.00134	0.0227	CbGeAlD
Topiramate—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00129	0.00137	CcSEcCtD
Topiramate—Rash—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00136	CcSEcCtD
Topiramate—Dermatitis—Cyclosporine—focal segmental glomerulosclerosis	0.00128	0.00136	CcSEcCtD
Topiramate—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00127	0.00135	CcSEcCtD
Topiramate—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00121	0.00128	CcSEcCtD
